[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: year 11, Issue 3 (July - August 2017) ::
Iran J Med Microbiol 2017, 11(3): 1-9 Back to browse issues page
Stem Cell Therapy in the Treatment of Parasitic Diseases
Safa Aryamand 1, Shahram Khademvatan 2, Kambiz Diba 1, Negar Manafpour 3, Esmaeil Abbassi 1
1- Cellular and Molecular Research Center & Department of Medical Parasitology and Mycology, Urmia University of Medical Sciences, Urmia, Iran
2- Cellular and Molecular Research Center & Department of Medical Parasitology and Mycology, Urmia University of Medical Sciences, Urmia, Iran , khademvatan@yahoo.com
3- Montgomery College, Maryland, USA, 20850
Abstract:   (1386 Views)

Stem cells are primary, unspecialized and mother of all cells that can differentiate into specialized cells and can produce more stem cells. These cells are classified into totipotent, pluripotent and multipotent. Stem cells have the remarkable potential to develop into many different cell types in the body and can replace damaged tissues and repaired them in the human body. Therefore, the use of stem cells shows the extraordinary ability to treat a wide range of disabling diseases. Stem cell therapy is the use of stem cells to treat or prevent a disease and injury. They stimulate the body to repair itself. Stem cells can be used for treating and preventing many diseases such as diabets, spinal cord injuries, cardiac infarction, arthritis, Alzheimer, Parkinson and wound healing. Researchers have recently used these cells to treat parasitic diseases in some cases. The findings show that the use of these cells in the treatment of various parasitic diseases such as malaria, trypanosomyosis, schistosomiasis, leishmaniasis and echinococcosis, have inhibitory effects which improves the function of the tissue and involved organs. This study summarizes the new advances in the stem cell therapy against parasitic infections.
 

Keywords: Stem cells, Treatment, Parasitic diseases
Full-Text [PDF 630 kb]   (538 Downloads)    
Type of Study: Review | Subject: Medical Parasitology
References
1. Lee K-D. Applications of mesenchymal stem cells: an updated review. Chang Gung Med J. 2008; 31(3):228-36. [PubMed]
2. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, et al. Embryonic stem cell lines derived from human blastocysts. science. 1998; 282(5391):1145-7. [PubMed]
3. Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proceedings of the National Academy of Sciences. 1981; 78(12):7634-8. [PubMed]
4. Qiao C, Xu W, Zhu W, Hu J, Qian H, Yin Q, et al. Human mesenchymal stem cells isolated from the umbilical cord. Cell biology international. 2008; 32(1):8-15. [PubMed]
5. Bobis S, Jarocha D, Majka M. Mesenchymal stem cells: characteristics and clinical applications. Folia Histochemica et Cytobiologica. 2006; 44(4):215. [PubMed]
6. Brunstein CG, Wagner JE. Umbilical cord blood transplantation and banking. Annu Rev Med. 2006; 57:403-17. [PubMed]
7. Johe KK, Hazel TG, Muller T, Dugich-Djordjevic MM, McKay R. Single factors direct the differentiation of stem cells from the fetal and adult central nervous system. Genes & development. 1996; 10(24):3129-40. [PubMed]
8. Gage FH. Mammalian neural stem cells. Science. 2000; 287(5457):1433-8. [PubMed]
9. Beachy PA, Karhadkar SS, Berman DM. Tissue repair and stem cell renewal in carcinogenesis. Nature. 2004; 432(7015):324-31. [PubMed]
10. Verfaillie CM. Hematopoietic stem cells for transplantation. Nature immunology. 2002; 3(4):314-7. [Article]
11. Roufosse CA, Direkze N, Otto W, Wright N. Circulating mesenchymal stem cells. The international journal of biochemistry & cell biology. 2004; 36(4):585-97. [PubMed]
12. Niwa H, Miyazaki J-i, Smith AG. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nature genetics. 2000; 24(4):372-6. [PubMed]
13. Gurtner GC, Callaghan MJ, Longaker MT. Progress and potential for regenerative medicine. Annu Rev Med. 2007; 58:299-312. [PubMed]
14. Zhao Y, Jiang Z, Zhao T, Ye M, Hu C, Yin Z, et al. Reversal of type 1 diabetes via islet β cell regeneration following immune modulation by cord blood-derived multipotent stem cells. BMC medicine. 2012; 10(1):3. [PubMed]
15. Voltarelli JC, Couri CE, Stracieri AB, Oliveira MC, Moraes DA, Pieroni F, et al. Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. Jama. 2007; 297(14):1568-76. [PubMed]
16. Salazar DL, Uchida N, Hamers FP, Cummings BJ, Anderson AJ. Human neural stem cells differentiate and promote locomotor recovery in an early chronic spinal cord injury NOD-scid mouse model. PloS one. 2010; 5(8):e12272. [Article]
17. Malliaras K, Kreke M, Marbán E. The stuttering progress of cell therapy for heart disease. Clinical Pharmacology & Therapeutics. 2011; 90(4):532-41. [PubMed]
18. Grinnemo K, Månsson A, Dellgren G, Klingberg D, Wardell E, Drvota V, et al. Xenoreactivity and engraftment of human mesenchymal stem cells transplanted into infarcted rat myocardium. The Journal of Thoracic and Cardiovascular Surgery. 2004; 127(5):1293-300. [PubMed]
19. Filardo G, Madry H, Jelic M, Roffi A, Cucchiarini M, Kon E. Mesenchymal stem cells for the treatment of cartilage lesions: from preclinical findings to clinical application in orthopaedics. Knee surgery, sports traumatology, arthroscopy. 2013; 21(8):1717-29. [PubMed]
20. Lindvall O, Kokaia Z, Martinez-Serrano A. Stem cell therapy for human neurodegenerative disorders–how to make it work. 2004. [PubMed]
21. Park BS, Jang KA, SUNG JH, PARK JS, Kwon YH, Kim KJ, et al. Adipose‐derived stem cells and their secretory factors as a promising therapy for skin aging. Dermatologic Surgery. 2008; 34(10):1323-6. [PubMed]
22. Khademvatan S, Adibpour N, Eskandari A, Rezaee S, Hashemitabar M, Rahim F. In silico and in vitro comparative activity of novel experimental derivatives against Leishmania major and Leishmania infantum promastigotes. Experimental parasitology. 2013; 135(2):208-16. [PubMed]
23. Khademvatan S, Gharavi M, Akhlaghi L, Samadikuchaksaraei A, Mousavizadeh K, Hadighi R, et al. Induction of apoptosis by miltefosine in Iranian strain of Leishmania infantum promastigotes. Iranian Journal of Parasitology. 2009; 4(2):23-31. [Article]
24. Khademvatan S, Abdizadeh R, Tavalla M. Molecular characterization of Toxocara spp. from soil of public areas in Ahvaz southwestern Iran. Acta tropica. 2014; 135:50-4. [PubMed]
25. Rai RC, Bhattacharya D, Das G. Stem cells in infectious diseases: INTECH Open Access Publisher; 2012.
26. Trager W, Jensen JB. Human malaria parasites in continuous culture. Science. 1976; 193(4254):673-5. [PubMed]
27. Salmanzadeh S, Foroutan-Rad M, Khademvatan S, Moogahi S, Bigdeli S. Significant decline of malaria incidence in southwest of Iran (2001–2014). Journal of tropical medicine. 2015; (2015): ID 523767. [Article]
28. Thakur RS, Tousif S, Awasthi V, Sanyal A, Atul P, Punia P, et al. Mesenchymal stem cells play an important role in host protective immune responses against malaria by modulating regulatory T cells. European journal of immunology. 2013; 43(8):2070-7. [PubMed]
29. Wang W, Qian H, Cao J. Stem cell therapy: a novel treatment option for cerebral malaria? Stem cell research & therapy. 2015; 6(1):141. [PubMed]
30. Khademvatan S, Gharavi MJ, Rahim F, Saki J. Miltefosine-induced apoptotic cell death on Leishmania major and L. tropica strains. The Korean journal of parasitology. 2011; 49(1):17-23. [PubMed]
31. Khademvatan S, Saki J, Maraghi S. Comparison of traditional methods and PCR for diagnosis of cutaneous leishmaniasis in South-West of Iran. Zahedan Journal of Research in Medical Sciences. 2012; 14(8):1-5. [Article]
32. Costa LE, Goulart LR, de Jesus Pereira NC, Lima MIS, Duarte MC, Martins VT, et al. Mimotope-based vaccines of Leishmania infantum antigens and their protective efficacy against visceral leishmaniasis. PloS one. 2014; 9(10):e110014. [PubMed]
33. Allahdin S, Khademvatan S, Hashemitabar M, Eskandari A. In vitro activity of Camellia sinensis extracts against L. major and L. infantum promastigotes using the colorometric MTT assay. Urmia Medical Journal. 2014; 25(10):893-900. [Article]
34. Khademvatan S, Saki J, Gharavi MJ, Rahim F. Allium sativum extract induces apoptosis in Leishmania major (MRHO/IR/75/ER) promastigotes. Journal of Medicinal Plants Research. 2011; 5(16):3725-32. [Article]
35. Mishra BB, Kale RR, Singh RK, Tiwari VK. Alkaloids: future prospective to combat leishmaniasis. Fitoterapia. 2009; 80(2):81-90. [PubMed]
36. Kolodziej H, Kiderlen AF. Antileishmanial activity and immune modulatory effects of tannins and related compounds on Leishmania parasitised RAW 264.7 cells. Phytochemistry. 2005; 66(17):2056-71. [PubMed]
37. Dameshghi S, Zavaran-Hosseini A, Soudi S, Shirazi FJ, Nojehdehi S, Hashemi SM. Mesenchymal stem cells alter macrophage immune responses to Leishmania major infection in both susceptible and resistance mice. Immunology letters. 2016; 170:15-26. [PubMed]
38. Aufderheide AC, Salo W, Madden M, Streitz J, Buikstra J, Guhl F, et al. A 9,000-year record of Chagas' disease. Proceedings of the National Academy of Sciences. 2004; 101(7):2034-9. [Article]
39. Kowalska A, Kowalski P, Torres MÁT. Chagas disease–american trypanosomiasis. Polish Annals of Medicine. 2011; 18(1):156-67.
40. Soares MBP, Santos RRd. Current status and perspectives of cell therapy in Chagas disease. Memorias do Instituto Oswaldo Cruz. 2009; 104:325-32. [PubMed]
41. Soares MB, Lima RS, Rocha LL, Takyia CM, Pontes-de-Carvalho L, de Carvalho ACC, et al. Transplanted bone marrow cells repair heart tissue and reduce myocarditis in chronic chagasic mice. The American journal of pathology. 2004; 164(2):441-7. [PubMed]
42. Guarita-Souza L, Carvalho K, Woitowicz V, Rebelatto C, Senegaglia A, Hansen P, et al. Simultaneous autologous transplantation of cocultured mesenchymal stem cells and skeletal myoblasts improves ventricular function in a murine model of Chagas disease. Circulation. 2006; 114(1):120-4. [PubMed]
43. Khademvatan S, Salmanzadeh S, Foroutan-Rad M, Ghomeshi M. Elimination of urogenital schistosomiasis in Iran: past history and the current situation. Parasitology. 2016; 143(11):1390-6. [Article]
44. Xu H, Qian H, Zhu W, Zhang X, Yan Y, Zhang L, et al. Inhibition of culture supernatant of mesenchymal stem cells on macrophages RAW264. 7 activated by soluble egg antigen of Schistosoma japonicum. Zhongguo ji sheng chong xue yu ji sheng chong bing za zhi= Chinese journal of parasitology & parasitic diseases. 2011; 29(6):425-30. [Article]
45. Hofer S, Gloor S, Müller U, Mathis A, Hegglin D, Deplazes P. High prevalence of Echinococcus multilocularis in urban red foxes (Vulpes vulpes) and voles (Arvicola terrestris) in the city of Zürich, Switzerland. Parasitology. 2000; 120(2):135-42. [PubMed]
46. Wilson JF, Rausch R. Alveolar hydatid disease. The American journal of tropical medicine and hygiene. 1980; 29(6):1340-55. [PubMed]
47. Schubert A, Koziol U, Cailliau K, Vanderstraete M, Dissous C, Brehm K. Targeting Echinococcus multilocularis stem cells by inhibition of the Polo-like kinase EmPlk1. PLoS Negl Trop Dis. 2014; 8(6):e2870. [Article]
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA code


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Aryamand S, khademvatan S, Diba K, Manafpour N, Abbassi E. Stem Cell Therapy in the Treatment of Parasitic Diseases. Iran J Med Microbiol. 2017; 11 (3) :1-9
URL: http://ijmm.ir/article-1-709-en.html


year 11, Issue 3 (July - August 2017) Back to browse issues page
مجله میکروب شناسی پزشکی ایران Iranian Journal of Medical Microbiology
Persian site map - English site map - Created in 0.06 seconds with 30 queries by YEKTAWEB 3728